The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.
Uplizna Prices, Coupons, Copay Cards & Patient Assistance
Uplizna (inebilizumab) is a member of the selective immunosuppressants drug class and is commonly used for Immunoglobulin G4-Related Disease, and Neuromyelitis Optica Spectrum Disorder.
Uplizna prices
Intravenous Solution
cdon 100 mg/10 mL Uplizna intravenous solution from $137,952.50 for 30 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 30 (3 x 10 milliliters) | $4,598.42 | $137,952.50 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Uplizna Coupons, Copay Cards and Rebates
Uplizna offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Uplizna Amgen By Your Side Co-Pay Program
Eligible commercially insured patients may pay $0 per dose.
- Applies to:
- Uplizna
- Number of uses:
- Per prescription until program expires
Form more information phone: 833-875-4962 or Visit website
Patient Assistance & Copay Programs for Uplizna
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Uplizna (inebilizumab-cdon) Injection; IV
More information please phone: 866-316-7263 Visit website
Provider: Good Days Program
Eligibility requirements:- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
- Uplizna (inebilizumab-cdon) Injection; IV
More information please phone: 877-968-7233 Visit website
Provider: Amgen By Your Side: Uplizna
Eligibility requirements:- Contact program for details.
- Not disclosed
- Medically Necessary as determined by a Doctor
- The patient must also be residing in the US.
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Please visit www.Uplizna.com for more information.
- Uplizna (inebilizumab-cdon) Injection; IV
More information please phone: 844-469-4297 or 833-842-8477 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Uplizna (inebilizumab)
- Uplizna consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- En español